Innoviva (INVA) Cash from Operations (QoQ) (2010 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 223.14% |
| Jun 30, 2025 | -9.35% |
| Sep 30, 2024 | 196.10% |
| Jun 30, 2024 | 18.01% |
| Sep 30, 2023 | 182.35% |
| Jun 30, 2023 | 48.66% |
| Sep 30, 2022 | 143.98% |
| Jun 30, 2022 | -19.44% |
| Sep 30, 2021 | 213.70% |
| Jun 30, 2021 | 0.60% |
| Mar 31, 2021 | -1.38% |
| Dec 31, 2020 | 14.38% |
| Sep 30, 2020 | -6.56% |
| Jun 30, 2020 | 8.59% |
| Mar 31, 2020 | 9.83% |
| Dec 31, 2019 | 16.56% |
| Sep 30, 2019 | 1.60% |
| Jun 30, 2019 | -26.30% |
| Mar 31, 2019 | 24.08% |
| Dec 31, 2018 | 2.76% |
| Sep 30, 2018 | 16.22% |
| Jun 30, 2018 | 3.63% |
| Mar 31, 2018 | 4.29% |
| Dec 31, 2017 | 10.05% |
| Sep 30, 2017 | 92.10% |
| Jun 30, 2017 | -18.45% |
| Mar 31, 2017 | 31.66% |
| Dec 31, 2016 | 4.45% |
| Sep 30, 2016 | 62.02% |
| Jun 30, 2016 | 71.86% |
| Mar 31, 2016 | 4.81% |
| Dec 31, 2015 | 160.43% |
| Sep 30, 2015 | 22.17% |
| Jun 30, 2015 | 234.53% |
| Mar 31, 2015 | 64.95% |
| Dec 31, 2014 | 78.12% |
| Sep 30, 2014 | 61.27% |
| Jun 30, 2014 | -7.44% |
| Mar 31, 2014 | -26.67% |
| Dec 31, 2013 | 3.24% |
| Sep 30, 2013 | -147.58% |
| Jun 30, 2013 | 47.25% |
| Mar 31, 2013 | -30.43% |
| Dec 31, 2012 | 12.02% |
| Sep 30, 2012 | 19.79% |
| Jun 30, 2012 | 16.84% |
| Mar 31, 2012 | -62.99% |
| Dec 31, 2011 | -31.16% |
| Sep 30, 2011 | -8.86% |
| Jun 30, 2011 | 31.41% |
| Mar 31, 2011 | -71.79% |
| Dec 31, 2010 | 21.45% |